For emergency use, with reduced dose (ANSA) The Food and Drug Administration (FDA) has authorized the emergency use of the Pfizer-BioNTech vaccine for children aged 5 to 11, with a reduced dose (one third of that for adults) and two injections three weeks apart . A decision that affects some 28 million American children. If there is also a green light from the Centers for Disease Control and Prevention (CDC), the pediatric vaccination campa
The Food and Drug Administration (FDA) has authorized the emergency use of the Pfizer-BioNTech vaccine for children aged 5 to 11, with a reduced dose (one third of that for adults) and two injections three weeks apart .
A decision that affects some 28 million American children.
If there is also a green light from the Centers for Disease Control and Prevention (CDC), the pediatric vaccination campaign can begin next week.